Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes - Poll - MDSpire

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

  • By

  • Lu Han

  • Yiran Wang

  • Yueying Li

  • Xiaoyan Li

  • Jing Zhang

  • Yan Zhang

  • Mingfei Zhao

  • Haixia Chen

  • Huiying Zhang

  • Yingmei Wang

  • Fengxia Xue

  • Wenyan Tian

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

  • by Lu Han, Yiran Wang, Yueying Li, Xiaoyan Li, Jing Zhang, Yan Zhang, Mingfei Zhao, Haixia Chen, Huiying Zhang, Yingmei Wang, Fengxia Xue, Wenyan Tian

  • May 20, 2026

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Pulsatile GnRH Pump Therapy Leads to Ovulation and Pregnancy in a Patient with Polycystic Ovary Syndrome: A Case Study

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.